73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Veralto Corp
Closed
SectorHealthcare
99.55 -1.73
Overview
Share price change
24h
Min
99.5
Max
101.34
Income | 17M 239M |
|---|---|
Sales | 33M 1.4B |
P/E Sector Avg | 27.808 88.032 |
EPS | 0.95 |
Dividend yield | 0.43 |
Profit margin | 17.023 |
Employees | 17,000 |
EBITDA | 15M 347M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +9.09% upside |
Dividend yield Sector Avg | 0.43% 2.26% |
|---|---|
Next Ex Dividend date | 30 Jan 2026 |
Market Cap | -636M 25B |
|---|---|
Previous open | 101.28 |
Previous close | 99.55 |
News Sentiment
By Acuity
50%
50%
157 / 374 Healthcare
Veralto Corp Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Veralto Corp Forecast
Price Target
By TipRanks
9.09% upside
12 Months Forecast
Average 110.57 USD 9.09%
High 121 USD
Low 100 USD
Based on 7 Wall Street analysts offering 12 month price targets forVeralto Corp - Dist in the last 3 months.
Sentiment
By Acuity
157 / 374 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Veralto Corp
Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands. This segment provides water solutions, including chemical reagents, services, and digital solutions. The PQI segment offers inline printing solutions for products and packaging with marking and coding systems; marking and coding for packaged goods and related consumables; design software and imaging systems for the creation of new packaging designs; color management solutions for printed packages and consumer and industrial products; color standard services for the design industry; and a software solution that provides digital asset management, marketing resource management, and product information management. This segment sells its products and services through the Videojet, Linx, Esko, X-Rite, and Pantone brands to regulated industries, including municipal utilities, food and beverage, pharmaceutical, and industrials. The company was formerly known as DH EAS Holding Corp. and changed its name to Veralto Corporation in February 2023. Veralto Corporation was incorporated in 2022 and is headquartered in Waltham, Massachusetts.
Live chat